Literature DB >> 3313362

Critical review of clinical trials in senile dementia--II.

J M Orgogozo1, R Spiegel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3313362      PMCID: PMC2428476          DOI: 10.1136/pgmj.63.739.337

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  104 in total

1.  [Demonstration of the therapeutic activity of 5023 SE on intellectual and psychomotor efficacy in elderly impaired patients. Double-blind controlled study versus placebo].

Authors:  P Berthaux; R Laforestrie
Journal:  Presse Med       Date:  1983-03-24       Impact factor: 1.228

2.  Effects of naloxone in senile dementia: a double-blind trial.

Authors:  B Reisberg; S H Ferris; R Anand; P Mir; V Geibel; M J De Leon; E Roberts
Journal:  N Engl J Med       Date:  1983-03-24       Impact factor: 91.245

Review 3.  The efficacy of the cerebral metabolic enhancers in the treatment of senile dementia.

Authors:  R J Branconnier
Journal:  Psychopharmacol Bull       Date:  1983

4.  Effects of 4-aminopyridine in elderly patients with Alzheimer's disease.

Authors:  H Wesseling; S Agoston; G B Van Dam; J Pasma; D J DeWit; H Havinga
Journal:  N Engl J Med       Date:  1984-04-12       Impact factor: 91.245

5.  No effect from double-blind trial of physostigmine and lecithin in Alzheimer disease.

Authors:  A Wettstein
Journal:  Ann Neurol       Date:  1983-02       Impact factor: 10.422

6.  The Sandoz Clinical Assessment-Geriatric (SCAG) scale. A general-purpose psychogeriatric rating scale.

Authors:  R D Venn
Journal:  Gerontology       Date:  1983       Impact factor: 5.140

Review 7.  Ergoloid mesylates for senile dementias: unanswered questions.

Authors:  L E Hollister; J Yesavage
Journal:  Ann Intern Med       Date:  1984-06       Impact factor: 25.391

8.  Alaproclate: a pharmacokinetic and biochemical study in patients with dementia of Alzheimer type.

Authors:  I Bergman; G Bråne; C G Gottfries; K G Jostell; I Karlsson; L Svennerholm
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

9.  Oral physostigmine and lecithin improve memory in Alzheimer disease.

Authors:  L J Thal; P A Fuld; D M Masur; N S Sharpless
Journal:  Ann Neurol       Date:  1983-05       Impact factor: 10.422

10.  Enhancement of memory processes in Alzheimer's disease with multiple-dose intravenous physostigmine.

Authors:  K L Davis; R C Mohs
Journal:  Am J Psychiatry       Date:  1982-11       Impact factor: 18.112

View more
  1 in total

Review 1.  Tetrahydroaminoacridine (THA) in Alzheimer's disease.

Authors:  J Byrne; T Arie
Journal:  BMJ       Date:  1989-04-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.